Legend Biotech Corp (LEGN)
40.94
+1.19
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
40.95
+0.01
(+0.02%)
After-Hours: 20:00
Legend Biotech Revenue (Quarterly): 160.20M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 160.20M |
June 30, 2024 | 186.52M |
March 31, 2024 | 93.99M |
December 31, 2023 | 79.46M |
September 30, 2023 | 96.01M |
June 30, 2023 | 73.33M |
March 31, 2023 | 36.34M |
December 31, 2022 | 27.63M |
September 30, 2022 | 27.36M |
June 30, 2022 | 11.97M |
March 31, 2022 | 50.04M |
December 31, 2021 | 18.03M |
Date | Value |
---|---|
September 30, 2021 | 16.88M |
June 30, 2021 | 20.23M |
March 31, 2021 | |
December 31, 2020 | 40.11M |
September 30, 2020 | 11.75M |
June 30, 2020 | 11.60M |
March 31, 2020 | 11.55M |
December 31, 2019 | 19.45M |
September 30, 2019 | 17.67M |
June 30, 2019 | 10.09M |
March 31, 2019 | 10.05M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
11.55M
Minimum
Mar 2020
186.52M
Maximum
Jun 2024
52.23M
Average
27.63M
Median
Dec 2022
Revenue (Quarterly) Benchmarks
Johnson & Johnson | 22.47B |
Ligand Pharmaceuticals Inc | 51.81M |
CEL-SCI Corp | -- |
AIM ImmunoTech Inc | 0.035M |
IGC Pharma Inc | 0.412M |
Revenue (Quarterly) Related Metrics
Net Income (Quarterly) | -125.32M |
Total Expenses (Quarterly) | 230.26M |
EPS Diluted (Quarterly) | -0.70 |
Enterprise Value | 6.595B |
Gross Profit Margin (Quarterly) | 65.38% |
Profit Margin (Quarterly) | -78.23% |
Earnings Yield | -4.69% |
Normalized Earnings Yield | -5.199 |